Compare CLLS & AFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | AFB |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 313.3M |
| IPO Year | 2014 | N/A |
| Metric | CLLS | AFB |
|---|---|---|
| Price | $3.24 | $10.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 48.3K | ★ 119.7K |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $9.78 |
| 52 Week High | $5.48 | $11.13 |
| Indicator | CLLS | AFB |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 20.68 |
| Support Level | $3.32 | $10.11 |
| Resistance Level | $3.83 | $10.93 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 22.37 | 14.29 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Alliancebernstein National Muni Inc Fd is a diversified, closed-end management investment company. It seeks to provide high current income exempt from regular federal income tax by investing substantially all of its net assets in municipal securities that pay interest that is exempt from federal income tax.